Clear Acne Kit

Acne Kit

Kamedis
Human Otc Drug
NDC 50718-0034

Clear Acne Kit also known as Acne Kit is a human otc drug labeled by 'Kamedis'. National Drug Code (NDC) number for Clear Acne Kit is 50718-0034. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Clear Acne Kit drug includes . The currest status of Clear Acne Kit drug is Active.

Drug Information:

Drug NDC:	50718-0034
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Clear Acne Kit
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Acne Kit
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Kamedis
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Kit
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Jan, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number:	part333D
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Kamedis
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:	103568 346298 1038982 2200082
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0893353000250
UPC stands for Universal Product Code.
UNII:
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
50718-0034-1	1 KIT in 1 CARTON (50718-0034-1) * 1 BOTTLE in 1 CARTON (50718-0032-1) / 22 mL in 1 BOTTLE * 1 BOTTLE in 1 CARTON (50718-0033-1) / 50 mL in 1 BOTTLE * 1 BOTTLE in 1 CARTON (50718-0031-1) / 100 mL in 1 BOTTLE	01 Jan, 2018	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Clear Acne Kit

Acne Kit

Kit
Kamedis
NDC: 50718-0034

Purpose:

Purpose acne treatment

Product Elements:

Clear acne kit acne kit clear acne face cleanser acne face cleanser salicylic acid salicylic acid benzyl alcohol purslane chlorphenesin glycerin hexylene glycol propanediol water xanthan gum sodium hydroxide squalane cocamidopropyl betaine glyceryl stearate se coco monoethanolamide lauroyl lysine myristic acid sodium chloride sapindus mukorossi fruit sodium lauroyl methyl isethionate sodium methyl cocoyl taurate stearic acid edetate sodium trisodium ethylenediamine disuccinate .alpha.-tocopherol acetate hydrolyzed jojoba esters (acid form) sodium cocoyl apple amino acids methyl glucose clear acne spot treatment acne spot treatment salicylic acid salicylic acid (c10-c30)alkyl methacrylate ester alcohol phellodendron amurense bark scutellaria baicalensis root benzyl alcohol capryloyl glycine chlorphenesin chrysanthemum indicum flower purslane glycerin rheum palmatum root sanguisorba officinalis root picea abies wood propanediol sarcosine hexasodium phytate tromethamine water xanthan gum cinnamon bark oil hexylene glycol clear acne face moisturizer acne face moisturizer salicylic acid salicylic acid arachidyl alcohol alcohol arachidyl glucoside ascorbyl tetraisopalmitate scutellaria baicalensis root benzyl alcohol capryloyl glycine cetyl alcohol purslane chlorphenesin rheum palmatum root chrysanthemum indicum flower dicaprylyl carbonate glycerin hexylene glycol picea abies wood propanediol sarcosine water xanthan gum cinnamon bark oil shea butter sodium hydroxide hexasodium phytate squalane stearyl alcohol docosanol phenylethyl alcohol carbomer interpolymer type a (55000 cps) dextrose, unspecified form nori

Indications and Usage:

Use for the treatment of acne

Warnings:

Warnings for external use only

When Using:

When using this product avoid contact with the eyes. if contact occurs, rinse eyes thoroughly with water. using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin. if this occurs, only one medication at a time should be used, unless otherwise directed by a doctor.

When using this product avoid unnecessary sun exposure and use sunscreen. avoid contact with the eyes. if contact occurs, rinse eyes thoroughly with water. using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin. if this occurs, only one medication at a time should be used, unless otherwise directed by a doctor.

Dosage and Administration:

Directions wet face. apply to hands, add water and work into lather. gently massage all over face avoiding eye area. rinse thoroughly and pat dry. good for daily use. cover the entire affected area with a thin layer one to three times daily. because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day for children under 10 years of age, consult your physician.

Directions cleanse the skin thoroughly before applying medication. cover the entire affected area with a thin layer one to three times daily. because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day. for children under 10 years of age, consult your physician.

Stop Use:

Stop use and ask a doctor if irritation persists

Package Label Principal Display Panel:

Carton label image description image description image description image description

Further Questions:

Questions or comments? 1-855-626-6606

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.